XM does not provide services to residents of the United States of America.

Trump tariffs could wipe out Europe's 2025 EPS growth, GS finds



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>LIVE MARKETS-Trump tariffs could wipe out Europe's 2025 EPS growth, GS finds</title></head><body>

STOXX 600 down 0.4%

ASML, Novo fall

Nasdaq futures down 1.2%

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

TRUMP TARIFFS COULD WIPE OUT EUROPE'S 2025 EPS GROWTH, GS FINDS

With prediction markets giving a 70% chance of Donald Trump being re-elected in November's U.S. presidential election, concern is rising over the economic and earnings impact of U.S. tariffs on Europe's export-oriented economy.

Goldman Sachs has done the maths, based on Trump's pledge to impose a 10% tariff on all U.S. imports. It concludes that euro area growth could take a 1-percentage point hit, which could potentially wipe out all European EPS growth next year.

"For Europe, the prime concern is tariffs," writes a team of GS strategists led by Sharon Bell.

According to the Wall Street bank, the economic damage would trickle down to earnings growth across Europe. Offsets such as a stronger dollar and U.S. tax cuts would be a small positive.

"Overall, we estimate the hit to Europe EPS would be about 6-7pp. If the entire impact came in 2025, this would be enough to eliminate any growth that year," they warned.

Goldman currently sees 4% EPS growth next year for Europe. Machinery/equipment, pharmaceuticals, chemicals and autos make up the largest share of European exports to the U.S., it notes.

If that weren't enough, tariffs against China could add another layer of stress to Europe Inc.

"There is also the potential for dumping of goods on Europe, especially from China if tariffs are imposed on goods going into the US. This has the potential to hit the Autos and Chemicals industries in particular," GS said.


(Danilo Masoni)

*****


PREVIOUSLY, ON LIVE MARKETS:

BANK OF ENGLAND'S CRUEL SUMMER CLICK HERE

DRUGS AND CHIPS DRIVE THE STOXX CLICK HERE

LET THE CHIPS FALL WHERE THEY MAY CLICK HERE

GOLD GLITTERS, INFLATION JITTERS CLICK HERE


</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.